High occurrence of CYP3A5 variants among breast cancer and organ transplant patients
Abstract CYP3A5 is one of the important drug metabolising enzyme and its polymorphism shows marked differences in protein expression and catalytic activities between different geographical ethnic groups. Both tamoxifen and tacrolimus are substrates of CYP3A5 and thus the polymorphism may cause phar...
Main Authors: | Ismail, S, Mohammad, NI, Hamzah, S, Mohamad , R, Harun, R, Suhaimi, S, Jaszle, S, Sood, S, Henry, F, Shabery, A, Rajoo, T, Bahri, R, Muniandy, S, Ismail, G, Wong, H. S., Abdullah Ngow, Harris, U Kyaw, T. H., Jalaludin, K, Din, J, Hatta, F. H., Teh, L. K., Salleh, M. Z. |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/5235/ http://irep.iium.edu.my/5235/ http://irep.iium.edu.my/5235/1/Abstract_for_NCCR_2010_cyp3a5a.pdf |
Similar Items
-
Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study
by: Ngow, Harris Abdullah, et al.
Published: (2008) -
Genetic Polymorphism of CYP2D6 and MDR1 in breast cancer patients treated with tamoxifen
by: Mohamad, NI, et al.
Published: (2010) -
The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1
by: Teh, L. K., et al.
Published: (2011) -
Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin
by: Teh, L. K., et al.
Published: (2011) -
The role of pharmacogenetic variation in metoprolol CYP2D6 genotypes polymorphism
by: Wan Sulaiman, Wan Mohd. Azizi, et al.
Published: (2011)